IBD Flashcards
Site of Crohns/UC
Crohns - Anywhere in GI + perianal/perineal skin
UC - colon & rectum
Crohns/UC - gender, age
Crohns - Slight female preponderance
- bimodal distribution peaks at 20-30 and 50-60
UC - M=F
Crohns/UC - incidence
Crohns - increasing
UC - stable
Crohns/UC - distribution
Crohns - patchy, skip lesions, transmural (affects full thickness of bowel wall - edematous and thickened)
UC - Diffuse, continuous, no skip lesions - except catcall patch +/- appendix.
Mucosa and submucosa
Crohns/UC - presentation
Crohns - Variable; Pain (usually right lower quadrant); Diarrhoea (usually no blood or mucus); Weight loss (avoid food as it causes pain; may be malabsorbed, vitamin deficiencies)
UC - bloody diarrhea
Crohns/UC - granulomas? Ulcers?
Crohns
Yes - may be transmural and in lymph nodes
Deep fissuring ulcers
UC - No granulomas.
Broad-based, shallow ulcers
Crohns/ UC - fistula? strictures?
Crohns - Yes for both
- Enteroenteric - cause diarrhea and malabsorption due to blind loop syndrome
- entervesical - recurrent UTI and pneumaturia
- enterovaginal - faeculent discharge
UC - no for both
Crohns/ UC - inflammatory polyps?
Crohns - less common but may be larger than in UC
UC - yes
Features of crohns
Pyloric metaplasia in small intestine
“cobblestone” mucosa from intersecting linear ulcers
Features of UC
Paneth cell metaplasia
Effect of smoking in UC/ Crohns
Crohns - bad
UC - protective
Crohns typical histology features
patchy inflammation with lymphoid aggregates
UC typical histology features
cry-titis, crypt abscesses, crypt architectural distortion and crypt loss in chronic UC
Goblet cell depletion
What are extra-intestinal manifestations of IBD?
Musculoskeletal
- arthritis, ankylosing spondylitis CD +++ / UC +
Hepatobiliary
- primary sclerosing cholangitis CD + / UC +++
- bile duct carcinoma CD+ / UC +++
Skin disorders
- erythema nodusum CD +++ / UC +++
- pyoderma gangrenosum CD+ / UC +++
Other
- oral ulceration CD +++/ UC +
- eye lesions CD+++ / UC +++
- amyloid (rare) CD+++ / UC +
DD of IBD
(1) Other forms of colitis
- crohns disease
- ischemic colitis
infective colitis (bacterial, parasitic) - salmonella, shigella, campylobacter jejuni, enteropathogen E coli, C. diff “pseudomembranous colitis”
- drug induced colitis
- microscopic colitis
(2) Colo-rectal neoplasm/ polyp
(3) Diverticular disease
(4) IBS
What is toxic megacolon?
Possible complication
Colon dilates and bacterial toxins pass freely across diseased mucosa into the portal and then systemic circulation
Most common during first attack of colitis
Abdo xray should be taken daily because when transverse or right colon is >6cm dilated, high risk of perforation - high associated mortality.
Loss of haustration in patients with severe UC
50% resolve with medical therapy alone but urgent colectomy required for those that do not improve.
IBD investigations + possible results
FBC
- May be anaemic due to malabsorption of (iron, folic acid, Vit B12) or bleeding
- Platelet count can be high as a marker of chronic inflammation
- Albumin falls due to protein-losing enteropathy, inflammatory disease, poor nutrition
- ESR & CRP increased in exacerbations and in response to abscess formation
Faecal calprotectin
- Detects GI inflammation – indicates migration of neutrophils to intestinal mucosa
- May be high when CRP is normal
- Good at distinguishing IBD from IBS
Bacteriology
- Stool microscopy, culture – C. diff, ova, cysts
- Blood cultures
- Should still be done in established disease to exclude superimposed enteric infections
Endoscopy
- Diarrhoea & raised inflammatory markers/alarm features
- UC – loss of vascular pattern, granularity, friability, contact bleeding, with/without ulceration
- Crohns – patchy inflammation, discrete deep ulcers, strictures, perianal disease (fissures, fistulae, skin tags) – often rectal sparing
- CT / MRI
Endoscopy findings in crohns / UC
UC
- loss of vascular pattern
- granularity
- friability
- contact bleeding
- with/without ulceration
Crohns
- patchy inflammation
- discrete deep ulcers
- strictures
- perianal disease (fissures, fistulae, skin tags)
- often rectal sparing
Crohns - treatment
Resuscitation: correct metabolic and nutritional disturbances
Treat active disease – medical or surgical
Achieving remission
1st line = Corticosteroids
- Prednisolone, methylprednisolone, IV hydrocortisone
2nd line = Budesonide (for ileocaecal, distal ileal or right-sided colonic disease)
Primary nutritional therapy
- Enteral nutrition – rests the gut & nutritional support, direct anti-inflammatory effect too
- Only considered in children / young people
High dose 5-ASA (4g/day) - mesalazine
Metronidazole (perianal disease)
TNFalpha antibody
Do not offer budesonide or 5-ASA treatment for severe presentations
Crohns - maintenance of remission treatment
Maintenance of remission
Stop smoking
(1) Azathioprine • Minor toxicity relatively common • Nausea, fever, skin rash & malaise • Pancreatitis 3-7% • Bone marrow depression 2% • Allergic reactions 2% • Drug-induced hepatitis 0.3% • TPMT testing = routine clinical practice
(2) Methotrexate
• Decreased rate of nausea with concomitant daily folic acid & metoclopramide/ ondansetron peri-injection
• SE: ulcerative stomatitis, leukopenia, nausea, malaise, fatigue, chills & fever, dizziness,
(3) Anti-TNF therapy
• Infliximab
• 755 human IgG1 molecule & 25% murine
• binds with high affinity to soluble and membrane bound TNFalpha
• SE: TB, other serious infections, post-operative complications, malignancy, lupus, immunogenicity and allergy
• More effective in early Crohns
ASA compounds >2g/day (post-operative)
(4) Vedolizumab
• Monoclonal antibody against anti-alpha4,beta7 integrin (expressed on specific subset of CD4+ leucocytes)
Crohns - surgery
75% require intestinal operation
39-53% require a second operation
Indications
• Sepsis – fistulae, abscess, perforation
• Obstruction
• Failure of medical treatment
• Haemorrhage
• Growth retardation, haemorrhage, fulminant colitis
• Cancer
Azathioprine SE
Azathioprine inhibit purine synthesis.
SE: • Minor toxicity relatively common • Nausea, fever, skin rash & malaise • Pancreatitis 3-7% • Bone marrow depression 2% • Allergic reactions 2% • Drug-induced hepatitis 0.3% • TPMT testing = routine clinical practice
Methotrexate SE
Decreased rate of nausea with concomitant daily folic acid & metoclopramide/ ondansetron peri-injection
SE: ulcerative stomatitis, leukopenia, nausea, malaise, fatigue, chills & fever, dizziness
Anti-TNF therapy side effects
Anti-TNF therapy
Infliximab
- 755 human IgG1 molecule & 25% murine
- binds with high affinity to soluble and membrane bound TNFalpha
SE: TB, other serious infections, post-operative complications, malignancy, lupus, immunogenicity and allergy
More effective in early Crohns